Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alphatec Holdings, Inc. ATEC

Healthcare  —  Medical Devices
10.12 0.20 2.02% as of 25 Sep
Market cap
$1.5B
P/E
0.0×
Revenue Champion (5y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Alphatec Holdings, Inc. (ATEC) Business Profile

Updated before January 2025

Company Overview

Alphatec Holdings, Inc. (ATEC) is a medical technology company specializing in the design, development, and advancement of innovative solutions for spinal surgery. Founded in 1990 and headquartered in Carlsbad, California, ATEC has established itself as a leader in the spine surgery market. The company’s mission is to revolutionize the approach to spine surgery by providing surgeons with cutting-edge tools and technologies that improve patient outcomes.

ATEC is led by a team of experienced professionals with deep expertise in the medical device and healthcare industries. The company’s CEO, Patrick Miles, has been instrumental in driving ATEC’s strategic vision and growth. Under his leadership, ATEC has focused on innovation, surgeon education, and the development of a comprehensive portfolio of spine surgery solutions.

Core Business Segments

ATEC operates in several core business segments, each focused on addressing specific needs in the spine surgery market. These segments include:

1. Spinal Implants

ATEC offers a wide range of spinal implants designed to address various spinal conditions, including degenerative disc disease, scoliosis, and trauma. Key products in this category include:

  • Arsenal Spinal Fixation System: A comprehensive system for posterior fixation.
  • Novel PEEK Interbody Devices: Designed for fusion procedures with enhanced biocompatibility.
  • Cervical and Lumbar Implants: Solutions for both anterior and posterior spinal surgeries.

2. Surgical Instruments

ATEC provides advanced surgical instruments that enable precision and efficiency during spine surgeries. These include:

  • SafeOp Neural InformatiX System: A neuromonitoring platform that enhances surgical safety.
  • Precision Instruments: Tools designed for minimally invasive and open surgical procedures.

3. Biologics

ATEC’s biologics portfolio includes products that promote bone growth and healing. These biologics are used in conjunction with spinal implants to improve surgical outcomes. Key offerings include:

  • AlphaGRAFT: A line of allograft tissue products.
  • Biologics for Fusion: Solutions that enhance bone fusion and regeneration.

4. Navigation and Robotics

ATEC is investing in advanced technologies such as navigation and robotics to improve surgical accuracy and outcomes. These systems integrate seamlessly with ATEC’s implants and instruments, providing surgeons with real-time guidance during procedures.

Business Model

ATEC’s business model is centered around innovation, integration, and surgeon education. The company generates revenue through the sale of its spinal implants, surgical instruments, and biologics. ATEC also provides training and support to surgeons, ensuring they are equipped to use its products effectively.

ATEC’s approach to integration involves combining its products and technologies into comprehensive solutions that address the full spectrum of spine surgery needs. This strategy not only enhances the value of ATEC’s offerings but also strengthens its relationships with surgeons and healthcare providers.

Strategic Direction

ATEC is committed to driving growth through innovation and strategic investments. The company’s future plans include:

  • Expanding Product Portfolio: ATEC aims to develop new products and technologies that address unmet needs in spine surgery.
  • Global Expansion: The company is exploring opportunities to expand its presence in international markets.
  • Sustainability Goals: ATEC is focused on reducing its environmental impact by adopting sustainable practices in its operations and product development.
  • Advancing Navigation and Robotics: ATEC plans to continue investing in navigation and robotics technologies to enhance surgical precision and outcomes.

Competitive Landscape

ATEC operates in a highly competitive market, facing competition from both established players and emerging companies. Key competitors include:

  • Medtronic: A global leader in medical technology with a strong presence in the spine surgery market.
  • NuVasive: Known for its innovative minimally invasive spine surgery solutions.
  • Stryker: Offers a comprehensive portfolio of spinal implants and surgical instruments.
  • Zimmer Biomet: A major player in the orthopedic and spine surgery markets.

Despite the competition, ATEC differentiates itself through its focus on innovation, surgeon education, and integrated solutions.

Risk Factors

ATEC faces several risks that could impact its business, including:

  • Market Dependence: The company’s revenue is heavily dependent on the spine surgery market, which is subject to fluctuations in demand and reimbursement rates.
  • Supply Chain Disruptions: ATEC relies on a global supply chain for its products, making it vulnerable to disruptions caused by geopolitical events, natural disasters, or pandemics.
  • Regulatory Challenges: The medical device industry is highly regulated, and ATEC must comply with stringent requirements to bring its products to market.
  • Competition: Intense competition from larger players with greater resources could impact ATEC’s market share.

Recent Developments

ATEC has made significant strides in recent years, including:

  • Launch of New Products: The company has introduced several new spinal implants and biologics to its portfolio.
  • Advancements in Navigation and Robotics: ATEC has continued to enhance its navigation and robotics systems, providing surgeons with state-of-the-art tools for spine surgery.
  • Strategic Partnerships: ATEC has formed partnerships with leading healthcare providers and research institutions to drive innovation and improve patient outcomes.
  • Response to Global Events: The company has adapted to challenges posed by the COVID-19 pandemic, ensuring the continuity of its operations and supply chain.

Investment Considerations

Investors considering ATEC should weigh the following strengths and risks:

Strengths

  • Strong focus on innovation and surgeon education.
  • Comprehensive portfolio of spinal implants, instruments, and biologics.
  • Commitment to advancing navigation and robotics technologies.
  • Experienced leadership team with a clear strategic vision.

Risks

  • Dependence on the spine surgery market and reimbursement rates.
  • Vulnerability to supply chain disruptions and regulatory challenges.
  • Intense competition from larger players in the medical device industry.

Conclusion

Alphatec Holdings, Inc. is a dynamic and innovative company that is well-positioned to capitalize on growth opportunities in the spine surgery market. With a strong focus on innovation, surgeon education, and integrated solutions, ATEC is poised for continued success. While the company faces risks such as market dependence and competition, its commitment to advancing technology and improving patient outcomes makes it an attractive option for investors and healthcare providers alike.